Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Stimulant / Ephedrine
Stimulant

Ephedrine

(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol

Ephedrine is a stimulant and decongestant, related to amphetamine, found in the ephedra plant and in some cold medicines. It is not a controlled substance, but pure ephedrine is a DEA List I chemical (a methamphetamine precursor), OTC sales are restricted under the Combat Methamphetamine Epidemic Act, and ephedra weight-loss supplements are FDA-banned over cardiac risks.

Overview

Ephedrine is a sympathomimetic stimulant and bronchodilator derived from Ephedra plants (ma huang) and also made synthetically. Medically it has been used as a decongestant, to treat low blood pressure during anesthesia, and for asthma. It became widely known in weight-loss and 'energy' supplements before those were banned in the US, and it is chemically related to amphetamine and to pseudoephedrine.

Source: FDA; DEA; MedlinePlus

Chemistry & mechanism of action

Ephedrine stimulates the sympathetic nervous system, both by triggering release of norepinephrine and by directly activating adrenergic receptors. This raises heart rate and blood pressure, opens the airways (bronchodilation), and constricts blood vessels. Its stimulant and appetite-suppressing effects, and its cardiovascular strain, all flow from this broad adrenergic activity.

Source: FDA; MedlinePlus; peer-reviewed literature (NIH/PMC)

Effects

Effects include increased alertness and energy, appetite suppression, decongestion, and opened airways, alongside raised heart rate, higher blood pressure, jitteriness, anxiety, insomnia, and palpitations. At higher doses the cardiovascular and neurological stimulation becomes pronounced. Tolerance to the stimulant effects can develop with repeated use.

Source: FDA; MedlinePlus

Risks & harms

Ephedrine's central danger is cardiovascular: it raises heart rate and blood pressure and has been linked to heart attack, stroke, dangerous arrhythmias, and death, particularly at high doses, with heavy use, in people with underlying heart conditions, or when combined with other stimulants such as caffeine — the combination common in the banned weight-loss supplements. The FDA banned ephedra (ephedrine-alkaloid) dietary supplements in the US because the risks outweighed benefits. Combining ephedrine with certain antidepressants (MAO inhibitors) can cause a dangerous spike in blood pressure. Overheating and agitation can occur with heavy use. Because pure ephedrine is a methamphetamine precursor, it is legally restricted (see the legal section), and products bought outside regulated channels may be mislabeled or contaminated. Anyone with chest pain, severe headache, signs of stroke, a very high heart rate, or a dangerously high blood pressure needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.

Source: FDA; peer-reviewed literature (NIH/PMC); MedlinePlus

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With stimulants, overheating and a racing heart are the main concerns — get somewhere cool, stop any physical activity, and don't take more.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
(1R,2S)-2-(methylamino)-1-phenylpropan-1-olPubChem PUG-REST · retrieved 2026-06-18
SMILES
C[C@@H]([C@@H](C1=CC=CC=C1)O)NCPubChem PUG-REST · retrieved 2026-06-18
InChIKey
KWGRBVOPPLSCSI-WPRPVWTQSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
l-Ephedrine, (-)-Ephedrine, Ephedrin, Mandrin, Ephedrol, Sanedrine, L(-)-Ephedrine, 1-Sedrin, Biophedrin, EphedremalPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
3 DOSAGE FORMS AND STRENGTHS Ephedrine sulfate injection, USP is a clear, colorless, sterile solution for intravenous injection available as: single-dose 1 mL vopenFDA drug label · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
See DailyMed label §Drug Interactions (Rx) — synthesize + cite per itemDailyMed SPL §Drug Interactions · retrieved 2026-06-18

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 5different versions. Make sure you’re looking at the right one — use the search above to find your exact pill by imprint, color, or shape.

Showing 5 of 5 variants

57 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
EPHEDRINE SULFATE 25 mg/1
Imprint
57 89
Color
white
Shape
OVAL
Form
TABLET, FILM COATED
Labeler
CVS Pharmacy, Inc
NDC
69842-922 · 2026-06-18
1298
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
EPHEDRINE HYDROCHLORIDE 12.5 mg/1
Imprint
1298
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Walgreen Company
NDC
0363-9812 · 2026-06-18
PT in circ
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
EPHEDRINE HYDROCHLORIDE 12.5 mg/1
Imprint
PT in circle engraved
Color
yellow
Shape
ROUND
Form
TABLET
Labeler
Foundation Consumer Brands
NDC
80070-600 · 2026-06-18
57 89
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
EPHEDRINE SULFATE 25 mg/1
Imprint
57 89
Color
white
Shape
OVAL
Form
TABLET, FILM COATED
Labeler
Walgreen Company
NDC
0363-5789 · 2026-06-18
BRONK25
Illustration based on reported characteristics. Appearance varies — identical-looking pills can contain completely different substances. Always test.
Strength
EPHEDRINE SULFATE 25 mg/1
Imprint
BRONK25
Color
WHITE
Shape
OVAL
Form
TABLET, COATED
Labeler
Foundation Consumer Healthcare LLC
NDC
69536-250 · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index